UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6026
Rush Enterprises Class B
RUSHB
$6.14B
| $378K | ﹤0.01% |
6,938
+1,459
| +27% | +$75.8K |
|
|
ALAR
6027
Alarum Technologies
ALAR
$14.3M
| $377K | ﹤0.01% |
35,564
+5,950
| +20% | +$77.2K |
|
6028
ProFrac Holding
ACDC
$787M
| $376K | ﹤0.01% |
48,490
-87,482
| -64% | -$628K |
|
6029
SIGA Technologies
SIGA
$219M
| $376K | ﹤0.01% |
62,609
+30,310
| +94% | +$203K |
|
|
ANSC
6030
Agriculture & Natural Solutions Acquisition Corp
ANSC
$476M
| $375K | ﹤0.01% |
35,767
+35,692
| +47,589% | +$372K |
|
|
ZYXI
6031
DELISTED
Zynex
ZYXI
| $375K | ﹤0.01% |
46,773
+41,393
| +769% | +$341K |
|
6032
FinWise Bancorp
FINW
$195M
| $375K | ﹤0.01% |
23,442
+23,441
| +2,344,100% | +$399K |
|
6033
Parke Bancorp
PKBK
$405M
| $374K | ﹤0.01% |
18,243
-11,083
| -38% | -$242K |
|
|
RSVR
6034
Reservoir Media
RSVR
$667M
| $374K | ﹤0.01% |
41,341
+6,444
| +18% | +$56.8K |
|
6035
ProShares UltraPro Short S&P 500
SPXU
$389M
| $374K | ﹤0.01% |
4,146
-9,240
| -69% | -$837K |
|
6036
ProShares Short 20+ Year Treasury ETF
TBF
$104M
| $372K | ﹤0.01% |
15,107
+15,013
| +15,971% | +$354K |
|
6037
CALL
Brown-Forman Class B
BF.B
$13.1B
| $372K | ﹤0.01% |
+9,800
| New | +$431K |
|
6038
Dimensional International High Profitability ETF
DIHP
$6.56B
| $372K | ﹤0.01% |
14,739
-969
| -6% | -$25.5K |
|
6039
Ideal Power
IPWR
$74.2M
| $370K | ﹤0.01% |
49,018
+536
| +1% | +$3.79K |
|
6040
iShares MSCI USA Size Factor ETF
SIZE
$442M
| $369K | ﹤0.01% |
2,484
-102
| -4% | -$15.5K |
|
6041
Heartbeam
BEAT
$29.1M
| $368K | ﹤0.01% |
160,002
| – | – |
|
|
BBOT
6042
BridgeBio Oncology
BBOT
$747M
| $367K | ﹤0.01% |
34,948
+34,927
| +166,319% | +$368K |
|
|
6043
Brown-Forman Class A
BF.A
$13.3B
| $366K | ﹤0.01% |
9,711
+1,049
| +12% | +$45.4K |
|
|
DRUG
6044
Bright Minds Biosciences
DRUG
$778M
| $366K | ﹤0.01% |
10,161
+6,754
| +198% | +$238K |
|
6045
iShares Paris-Aligned Climate Optimized MSCI USA ETF
PABU
$2.55B
| $366K | ﹤0.01% |
5,620
+896
| +19% | +$58.2K |
|
6046
Forum Energy Technologies
FET
$835M
| $365K | ﹤0.01% |
23,566
+17,978
| +322% | +$271K |
|
|
CTNM
6047
Contineum Therapeutics
CTNM
$566M
| $365K | ﹤0.01% |
24,881
+22,221
| +835% | +$352K |
|
6048
Fulcrum Therapeutics
FULC
$297M
| $364K | ﹤0.01% |
77,392
-3,241
| -4% | -$12K |
|
|
BRT
6049
BRT Apartments
BRT
$271M
| $363K | ﹤0.01% |
20,160
+12,902
| +178% | +$234K |
|
6050
Invesco High Income Trust II
VLT
$65.7M
| $363K | ﹤0.01% |
33,086
-500
| -1% | -$5.65K |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.